Event Details

BioLineRx to Deliver Oral Presentation at ESMO

Dec 13, 2019

Abstract title: A Multi-Center Phase 2a Trial to Assess the Safety and Efficacy of BL-8040 (a CXCR4 inhibitor) in Combination with Pembrolizumab and Chemotherapy in Patients with Metastatic Pancreatic Adenocarcinoma (PDAC)


Presentation No.: 91O

Lecture time: 11:00-11:30am CET

Location: Room C

Supporting Materials


Geneva, Switzerland